Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14296417 | 1.00 | FAAH (0.46) | FAAHCHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL14296416 | 1.00 | FAAH (0.46) | FAAHCHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL16665386 | 0.86 | FAAH (0.43) | FAAHCHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL20854298 | 0.86 | FAAH (0.43) | FAAHCHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL2332583 | 0.86 | FAAH (0.56) | FAAHTDP1CNR1CNR2TSHR | |
| SCHEMBL16554242 | 0.86 | FAAH (0.43) | FAAHCHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL16554070 | 0.86 | FAAH (0.43) | FAAHCHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL16554241 | 0.86 | FAAH (0.43) | FAAHCHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL16554067 | 0.86 | FAAH (0.43) | FAAHCHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL16554069 | 0.86 | FAAH (0.43) | FAAHCHRM1AKR1A1CHRM3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110981873-B | Preparation method for synthesizing pyrroloquinoline quinone by five-step method | 江西农业大学 | 2025-01-24 | — | — | CN | claimed |
| CN-110981873-B | Preparation method for synthesizing pyrroloquinoline quinone by five-step method | 江西农业大学 | 2025-01-24 | — | — | CN | disclosed |
| CN-109952360-B | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device | 东友精细化工有限公司 | 2022-03-22 | — | — | CN | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| US-20170196848-A1 | Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives | ALKERMES PHARMA IRELAND LTD (IE) | 2017-07-13 | — | — | US | disclosed |
| US-9585965-B2 | Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives | ALKERMES PHARMA IRELAND LIMITED (IE) | 2017-03-07 | — | — | US | disclosed |
| US-20150320875-A1 | Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives | ALKERMES PHARMA IRELAND LTD (IE) | 2015-11-12 | — | — | US | disclosed |
| US-9072788-B2 | Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives | ALKERMES PHARMA IRELAND LIMITED (IE) | 2015-07-07 | — | — | US | disclosed |
| US-8664423-B2 | Process for the preparation of acylated secondary alcohol alkoxylates and secondary alcohol alkoxylates | SHELL OIL COMPANY (US) | 2014-03-04 | — | — | US | disclosed |
| EP-2181763-B1 | Catalyst and process for alkoxylation | SHELL INT RESEARCH (NL) | 2012-06-20 | — | — | EP | disclosed |
| US-6313066-B1 | Decolorable image forming material and decoloring method of the same | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-11-06 | — | — | US | disclosed |
| US-6277208-B1 | HEATING IMAGE FORMING MATERIAL, CONTACTING WITH SOLVENT, DESOLVENTIZING, WHERE IMAGE FORMING MATERIAL CONTAINS A COLOR FORMER, A DEVELOPER AND A DECOLORIZER AND WHERE DECOLORIZER COMPRISES AMORPHOUS PHASE SEPARTION INHIBITORS | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-08-21 | — | — | US | disclosed |
| US-20010008164-A1 | DECOLORIZABLE INK AND PRINTER | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-07-19 | — | — | US | disclosed |
| US-6248692-B1 | MIXTURE OF COLOR FORMER, DEVELOPER AND DECOLORIZER FORMED BY ACTIVATION | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-06-19 | — | — | US | disclosed |
| US-6203603-B1 | COLOR FORMER, DEVELOPER, MATRIX AND POLYMER DECOLORIZER | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-03-20 | — | — | US | disclosed |
| EP-1041447-A1 | Decolorable image forming material and decoloring method of the same | Kabushiki Kaisha Toshiba (JP) | 2000-10-04 | — | — | EP | disclosed |
| EP-0987123-A2 | Erasable image forming material | KABUSHIKI KAISHA TOSHIBA (JP) | 2000-03-22 | — | — | EP | disclosed |
| EP-0980028-A1 | Erasable image forming material | KABUSHIKI KAISHA TOSHIBA (JP) | 2000-02-16 | — | — | EP | disclosed |
| US-6017386-A | A COLOR FORMER, A DEVELOPER AND A DECOLORIZER WHICH COMPRISES A CYCLIC SUGAR ALCOHOL AS HIGHLY AMORPHOUS PHASE SEPARATION INHIBITOR AND A NON AROMATIC SUBSTITUED CYCLIC SUGAR ALCOHOL AS SLIGHTLY AMORPHOUS PHASE SEPARATION INHIBITOR | KABUSHIKI KAISHA TOSHIBA (JP) | 2000-01-25 | — | — | US | disclosed |
| EP-0932084-A1 | Decoloring method of decolorizable image forming material | KABUSHIKI KAISHA TOSHIBA (JP) | 1999-07-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150320875-A1 | Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives | PHPT1, SI, CA6 | FAAH 807/4885CHRM1 2813/4885AKR1A1 1601/4885 |
| US-20170196848-A1 | Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives | PHPT1, SI, CA6 | FAAH 807/4885CHRM1 2813/4885AKR1A1 1601/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | FAAH 1494/4885CHRM1 1525/4885AKR1A1 875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.